WINTON GROUP Ltd - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$812,178
+37.3%
19,356
+24.8%
0.05%
+28.2%
Q4 2022$591,475
-0.3%
15,508
+2.4%
0.04%0.0%
Q3 2022$593,000
+8.2%
15,138
-10.7%
0.04%
+34.5%
Q2 2022$548,000
+21.0%
16,959
+24.0%
0.03%
+20.8%
Q1 2022$453,000
-6.8%
13,672
+19.7%
0.02%
-17.2%
Q4 2021$486,000
-71.4%
11,426
-70.2%
0.03%
-69.5%
Q3 2021$1,699,000
+55.4%
38,348
+99.3%
0.10%
+61.0%
Q2 2021$1,093,000
+65.4%
19,240
+117.8%
0.06%
+55.3%
Q1 2021$661,000
-29.2%
8,832
-18.2%
0.04%
-43.3%
Q4 2020$934,000
-69.8%
10,791
-78.7%
0.07%
-33.7%
Q3 2020$3,097,000
+32.0%
50,677
-10.2%
0.10%
+65.6%
Q2 2020$2,346,000
+74.2%
56,411
+202.3%
0.06%
+221.1%
Q4 2019$1,347,000
+228.5%
18,659
+539.2%
0.02%
+280.0%
Q3 2019$410,000
+59.5%
2,919
+8.9%
0.01%
-16.7%
Q4 2018$257,000
-47.9%
2,680
-23.2%
0.01%
-40.0%
Q3 2018$493,000
+12.3%
3,491
+24.6%
0.01%
-9.1%
Q2 2018$439,000
-23.9%
2,802
-21.7%
0.01%
-31.2%
Q1 2018$577,0003,5800.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders